Antineuronal antibody status and phenotype analysis in Tourette's syndrome.

Standard

Antineuronal antibody status and phenotype analysis in Tourette's syndrome. / Martino, Davide; Defazio, Giovanni; Church, Andrew J; Dale, Russell C; Giovannoni, Gavin; Robertson, Mary M; Orth, Michael.

in: MOVEMENT DISORD, Jahrgang 22, Nr. 10, 10, 2007, S. 1424-1429.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Martino, D, Defazio, G, Church, AJ, Dale, RC, Giovannoni, G, Robertson, MM & Orth, M 2007, 'Antineuronal antibody status and phenotype analysis in Tourette's syndrome.', MOVEMENT DISORD, Jg. 22, Nr. 10, 10, S. 1424-1429. <http://www.ncbi.nlm.nih.gov/pubmed/17516471?dopt=Citation>

APA

Martino, D., Defazio, G., Church, A. J., Dale, R. C., Giovannoni, G., Robertson, M. M., & Orth, M. (2007). Antineuronal antibody status and phenotype analysis in Tourette's syndrome. MOVEMENT DISORD, 22(10), 1424-1429. [10]. http://www.ncbi.nlm.nih.gov/pubmed/17516471?dopt=Citation

Vancouver

Martino D, Defazio G, Church AJ, Dale RC, Giovannoni G, Robertson MM et al. Antineuronal antibody status and phenotype analysis in Tourette's syndrome. MOVEMENT DISORD. 2007;22(10):1424-1429. 10.

Bibtex

@article{6de22f6886304683b5204a72e4c9bd75,
title = "Antineuronal antibody status and phenotype analysis in Tourette's syndrome.",
abstract = "The Gilles de la Tourette syndrome (GTS) spectrum includes psychiatric comorbidities, mainly obsessive-compulsive disorder (OCD) and attention-deficit-hyperactivity disorder (ADHD). The role of environmental factors, e.g., antineuronal antibodies (ANeA), remains unclear. We compared the clinical features of ANeA-positive and ANeA-negative patients in 53 children and 75 adults with GTS. All diagnoses were made according to DSM-IV-TR criteria. A positive ANeA Western immunoblot showed bands for at least 1 of 3 reported striatal antigens (40, 45, and 60 kDa). Twelve children (23%) and 18 adults (25%) with GTS were ANeA-positive. Disease duration, tic phenomenology and severity, frequency of echo/pali/coprophenomena, self-injurious and aggressive behavior, or frequency of OCD comorbidity did not significantly differ between ANeA-positive and negative patients. Similar findings were obtained analyzing separately the three different antibody reactivities. A comorbid diagnosis of ADHD was significantly less frequent in GTS patients positive for the anti-60 kDa antibody only. Using a multivariate logistic regression model, adjusting for age, gender, and age at disease onset, a comorbid diagnosis of ADHD remained inversely associated with anti-60 kDa antibodies (odds ratio = 0.14; P = 0.002; 95% confidence interval 0.04-0.49). ANeA status does not differentiate a specific phenotype of GTS.",
author = "Davide Martino and Giovanni Defazio and Church, {Andrew J} and Dale, {Russell C} and Gavin Giovannoni and Robertson, {Mary M} and Michael Orth",
year = "2007",
language = "English",
volume = "22",
pages = "1424--1429",
journal = "MOVEMENT DISORD",
issn = "0885-3185",
publisher = "John Wiley and Sons Inc.",
number = "10",

}

RIS

TY - JOUR

T1 - Antineuronal antibody status and phenotype analysis in Tourette's syndrome.

AU - Martino, Davide

AU - Defazio, Giovanni

AU - Church, Andrew J

AU - Dale, Russell C

AU - Giovannoni, Gavin

AU - Robertson, Mary M

AU - Orth, Michael

PY - 2007

Y1 - 2007

N2 - The Gilles de la Tourette syndrome (GTS) spectrum includes psychiatric comorbidities, mainly obsessive-compulsive disorder (OCD) and attention-deficit-hyperactivity disorder (ADHD). The role of environmental factors, e.g., antineuronal antibodies (ANeA), remains unclear. We compared the clinical features of ANeA-positive and ANeA-negative patients in 53 children and 75 adults with GTS. All diagnoses were made according to DSM-IV-TR criteria. A positive ANeA Western immunoblot showed bands for at least 1 of 3 reported striatal antigens (40, 45, and 60 kDa). Twelve children (23%) and 18 adults (25%) with GTS were ANeA-positive. Disease duration, tic phenomenology and severity, frequency of echo/pali/coprophenomena, self-injurious and aggressive behavior, or frequency of OCD comorbidity did not significantly differ between ANeA-positive and negative patients. Similar findings were obtained analyzing separately the three different antibody reactivities. A comorbid diagnosis of ADHD was significantly less frequent in GTS patients positive for the anti-60 kDa antibody only. Using a multivariate logistic regression model, adjusting for age, gender, and age at disease onset, a comorbid diagnosis of ADHD remained inversely associated with anti-60 kDa antibodies (odds ratio = 0.14; P = 0.002; 95% confidence interval 0.04-0.49). ANeA status does not differentiate a specific phenotype of GTS.

AB - The Gilles de la Tourette syndrome (GTS) spectrum includes psychiatric comorbidities, mainly obsessive-compulsive disorder (OCD) and attention-deficit-hyperactivity disorder (ADHD). The role of environmental factors, e.g., antineuronal antibodies (ANeA), remains unclear. We compared the clinical features of ANeA-positive and ANeA-negative patients in 53 children and 75 adults with GTS. All diagnoses were made according to DSM-IV-TR criteria. A positive ANeA Western immunoblot showed bands for at least 1 of 3 reported striatal antigens (40, 45, and 60 kDa). Twelve children (23%) and 18 adults (25%) with GTS were ANeA-positive. Disease duration, tic phenomenology and severity, frequency of echo/pali/coprophenomena, self-injurious and aggressive behavior, or frequency of OCD comorbidity did not significantly differ between ANeA-positive and negative patients. Similar findings were obtained analyzing separately the three different antibody reactivities. A comorbid diagnosis of ADHD was significantly less frequent in GTS patients positive for the anti-60 kDa antibody only. Using a multivariate logistic regression model, adjusting for age, gender, and age at disease onset, a comorbid diagnosis of ADHD remained inversely associated with anti-60 kDa antibodies (odds ratio = 0.14; P = 0.002; 95% confidence interval 0.04-0.49). ANeA status does not differentiate a specific phenotype of GTS.

M3 - SCORING: Journal article

VL - 22

SP - 1424

EP - 1429

JO - MOVEMENT DISORD

JF - MOVEMENT DISORD

SN - 0885-3185

IS - 10

M1 - 10

ER -